Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The clinical outcomes panel discussion session from ISTS 2014, held in Oxford this September, is now available to view on Youtube.

The clinical outcomes panel discussion session from the International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics, held in Oxford this September is now available to view on Youtube.

The event brought together an unprecedented mix of excellent basic and translational science and the finest clinical expertise, featuring twelve international plenary speakers, along with open papers and poster sessions. The Symposium was co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

For the first time in its three-edition history, the meeting was co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Abstracts from the meeting accepted for publication in BJSM are available on their website

Similar stories

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.

HOPE-c opens up for recruitment

Researchers in the Centre for OA Pathogenesis Versus Arthritis at the Kennedy Institute of Rheumatology and Imperial College London are looking to recruit adults with painful hand osteoarthritis for an observational study to help uncover why people living with the condition experience different patterns of pain.